{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T15:11:13Z","timestamp":1780672273481,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2009-1068"],"award-info":[{"award-number":["2009-1068"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010215","name":"Deutsche Diabetes Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010215","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013964","name":"Stiftelsen Stig och Gunborg Westman","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013964","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB TRR 219"],"award-info":[{"award-number":["SFB TRR 219"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1053\/j.ajkd.2023.05.010","type":"journal-article","created":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T20:44:48Z","timestamp":1693428288000},"page":"18-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia"],"prefix":"10.1053","volume":"83","author":[{"given":"Thomas","family":"Ebert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosheen","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marni","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Lamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Froissart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Floege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Stenvinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8980-2223","authenticated-orcid":false,"given":"James","family":"Fotheringham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 suppl 1","key":"10.1053\/j.ajkd.2023.05.010_bib1","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1053\/j.ajkd.2022.02.001","article-title":"US Renal Data System 2021 annual data report: epidemiology of kidney disease in the United States","volume":"79","author":"Johansen","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2023.05.010_bib2","series-title":"IDF Diabetes Atlas","year":"2021"},{"issue":"16","key":"10.1053\/j.ajkd.2023.05.010_bib3","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2009.1488","article-title":"Cardiovascular and noncardiovascular mortality among patients starting dialysis","volume":"302","author":"Jager","year":"2009","journal-title":"JAMA"},{"issue":"17","key":"10.1053\/j.ajkd.2023.05.010_bib4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1089\/ars.2020.8184","article-title":"Inflammation and oxidative stress in chronic kidney disease and dialysis patients","volume":"35","author":"Ebert","year":"2021","journal-title":"Antioxid Redox Signal"},{"issue":"10302","key":"10.1053\/j.ajkd.2023.05.010_bib5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","article-title":"Chronic kidney disease","volume":"398","author":"Kalantar-Zadeh","year":"2021","journal-title":"Lancet"},{"issue":"9854","key":"10.1053\/j.ajkd.2023.05.010_bib6","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2023.05.010_bib7","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2023.05.010_bib8","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1007\/s00125-007-0650-z","article-title":"Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study","volume":"50","author":"Hayashino","year":"2007","journal-title":"Diabetologia"},{"issue":"8","key":"10.1053\/j.ajkd.2023.05.010_bib9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/dc17-0110","article-title":"Association of glycemic status during progression of chronic kidney disease with early dialysis mortality in patients with diabetes","volume":"40","author":"Rhee","year":"2017","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1053\/j.ajkd.2023.05.010_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1210\/edrv-2-2-210","article-title":"Insulin metabolism and degradation","volume":"2","author":"Duckworth","year":"1981","journal-title":"Endocr Rev"},{"issue":"10","key":"10.1053\/j.ajkd.2023.05.010_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1463-1326.2007.00802.x","article-title":"Insulin therapy in renal disease","volume":"10","author":"Iglesias","year":"2008","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1053\/j.ajkd.2023.05.010_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrendo.2017.39","article-title":"Insulin analogues in type 1 diabetes mellitus: getting better all the time","volume":"13","author":"Mathieu","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1053\/j.ajkd.2023.05.010_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12020-021-02889-6","article-title":"Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials","volume":"74","author":"Mannucci","year":"2021","journal-title":"Endocrine"},{"issue":"4","key":"10.1053\/j.ajkd.2023.05.010_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00592-011-0320-y","article-title":"Comparison of human insulin and insulin analogues on hypoglycaemia and metabolic variability in type 1 diabetes using standardized measurements (HYPO score and Lability Index)","volume":"50","author":"P\u00e9rez-Maraver","year":"2013","journal-title":"Acta Diabetol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.05.010_bib15","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.18554","article-title":"Comparison of mortality and major cardiovascular events among adults with type 2 diabetes using human vs analogue insulins","volume":"3","author":"Neugebauer","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1053\/j.ajkd.2023.05.010_bib16","first-page":"CD013228","article-title":"Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus","volume":"12","author":"Fullerton","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1053\/j.ajkd.2023.05.010_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006341","article-title":"Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review","volume":"5","author":"Price","year":"2015","journal-title":"BMJ Open"},{"issue":"5","key":"10.1053\/j.ajkd.2023.05.010_bib18","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/nrneph.2015.38","article-title":"Haemodialysis-induced hypoglycaemia and glycaemic disarrays","volume":"11","author":"Abe","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2023.05.010_bib19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2337\/dc21-1579","article-title":"Hypoglycemic and hyperglycemic crises among U.S. adults with diabetes and end-stage kidney disease: population-based study, 2013-2017","volume":"45","author":"Galindo","year":"2021","journal-title":"Diabetes Care"},{"issue":"10225","key":"10.1053\/j.ajkd.2023.05.010_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"Lancet"},{"issue":"4","key":"10.1053\/j.ajkd.2023.05.010_bib21","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/joim.13291","article-title":"Time-dependent lipid profile inversely associates with mortality in hemodialysis patients\u2014independent of inflammation\/malnutrition","volume":"290","author":"Ebert","year":"2021","journal-title":"J\u00a0Intern Med"},{"issue":"5","key":"10.1053\/j.ajkd.2023.05.010_bib22","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ki.2014.419","article-title":"Development and validation of a predictive mortality risk score from a European hemodialysis cohort","volume":"87","author":"Floege","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2023.05.010_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001224","article-title":"Validation of a type 1 diabetes algorithm using electronic medical records and administrative healthcare data to study the population incidence and prevalence of type 1 diabetes in Ontario, Canada","volume":"8","author":"Weisman","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"10.1053\/j.ajkd.2023.05.010_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-016-4146-6","article-title":"Glucose concentrations of less than 3.0 mmol\/L (54 mg\/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"60","year":"2017","journal-title":"Diabetologia"},{"issue":"6","key":"10.1053\/j.ajkd.2023.05.010_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2023.05.010_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0962280217713032","article-title":"Propensity score analysis with partially observed covariates: how should multiple imputation be used?","volume":"28","author":"Leyrat","year":"2019","journal-title":"Stat Methods Med Res"},{"issue":"4","key":"10.1053\/j.ajkd.2023.05.010_bib27","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0167-9473(95)00057-7","article-title":"Partially parametric techniques for multiple imputation","volume":"22","author":"Schenker","year":"1996","journal-title":"Comput Stat Data Anal"},{"key":"10.1053\/j.ajkd.2023.05.010_bib28","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.ajkd.2023.05.010_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14775","article-title":"Excess all-cause and cause-specific mortality for people with diabetes and end-stage kidney disease","volume":"39","author":"Morton","year":"2022","journal-title":"Diabet Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2023.05.010_bib30","first-page":"S175","article-title":"11. Chronic kidney disease and risk management: standards of medical care in diabetes\u20142022","volume":"45","year":"2021","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.ajkd.2023.05.010_bib31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13098-018-0397-3","article-title":"Short-acting insulin analogues versus regular human insulin on postprandial glucose and hypoglycemia in type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"11","author":"Melo","year":"2019","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"10.1053\/j.ajkd.2023.05.010_bib32","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","article-title":"The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients","volume":"26","author":"Riddle","year":"2003","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1053\/j.ajkd.2023.05.010_bib33","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41574-021-00542-w","article-title":"One hundred years of insulin therapy","volume":"17","author":"Mathieu","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1053\/j.ajkd.2023.05.010_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107549","article-title":"Glycemic variability and all-cause mortality in patients with diabetes receiving hemodialysis: a prospective cohort study","volume":"34","author":"Shi","year":"2020","journal-title":"J\u00a0Diabetes Complications"},{"issue":"11","key":"10.1053\/j.ajkd.2023.05.010_bib35","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1111\/dom.14802","article-title":"The association of long-acting insulin analogue use versus neutral protamine Hagedorn insulin use and the risk of major adverse cardiovascular events among individuals with type 2 diabetes: a population-based cohort study","volume":"24","author":"Brunetti","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2023.05.010_bib36","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1038\/s41598-021-83253-6","article-title":"A\u00a0nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1053\/j.ajkd.2023.05.010_bib37","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ki.2015.117","article-title":"High cardiovascular event rates occur within the first weeks of starting hemodialysis","volume":"88","author":"Eckardt","year":"2015","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623007758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638623007758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:35:09Z","timestamp":1780670109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638623007758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S0272638623007758"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.05.010","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2023.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the National Kidney Foundation, Inc.","name":"copyright","label":"Copyright"}]}}